Market Snapshot

BSE Sensex: 73983.18 0.09%
BSE 500: 34766.59 -0.61%
BSE 200: 10832.79 -0.50%
BSE 100: 24673.65 -0.29%
BSE BANKEX: 62058.97 -0.33%
BSE IT: 27552.35 -0.85%
Nifty 50: 23214.95 -0.12%
Nifty 500: 22233.85 -0.61%
Nifty 200: 13397.8 -0.54%
Nifty 100: 24200.75 -0.31%
Nifty Midcap 100: 59810.2 -1.49%
Nifty Small 100: 17822.5 -1.33%
Nifty IT: 28279.9 -0.83%
Nifty PSU Bank: 8378.7 -1.39%

News:

NLC India ends steeply lower a...
Lenskart Solutions acquires ba...
Motisons Jewellers gains after...
Tata Capital appoints Kamal Bh...
Stanley Lifestyles bags Rs 2-c...

Balaxi Pharmaceuticals Ltd Share Price – NSE
Pharmaceuticals, Small Cap

Invest

10 Jun 2026 | 04:14 PM

24.31

0.09 (0.37%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-55.39%

Return (1Y)

Underperformed Nifty 50 by 47.86%
More Volatile

3.02%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.2%
Inconsistent Performer

1/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

64

15

News & Announcements

Balaxi Pharmaceuticals to conduct AGM
10 days ago

Balaxi Pharmaceuticals to conduct AGM

01 - Jun - 2026 12:00 | 10 days ago

Balaxi Pharmaceuticals announced that the 83th Annual General Meeting(AGM) of the company will be held on 24 August 2026.

Balaxi Pharmaceuticals consolidated net profit declines 92.94% in the March 2026 quarter

13 days ago

Balaxi Pharmaceuticals to hold board meeting
31 days ago

Balaxi Pharmaceuticals to hold board meeting

11 - May - 2026 12:00 | 31 days ago

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 May 2026.
Balaxi Pharmaceuticals consolidated net profit declines 94.22% in the December 2025 quarter
129 days ago

Balaxi Pharmaceuticals consolidated net profit declines 94.22% in the December 2025 quarter

02 - Feb - 2026 12:00 | 129 days ago

Net profit of Balaxi Pharmaceuticals declined 94.22% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 5.36 crore during the previous quarter ended December 2024. Sales declined 1.02% to Rs 72.54 crore in the quarter ended December 2025 as against Rs 73.29 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 72.54 73.29 -1

OPM % 4.26 5.44 -

PBDT 2.17 6.55 -67

PBT 1.61 6.07 -73

NP 0.31 5.36 -94

Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in Balaxi Pharmaceuticals Ltd has decreased by -100% since past 3 Months
FII shareholding in Balaxi Pharmaceuticals Ltd has decreased by -100% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60